Shattuck Labs, Inc. (STTK) stock
STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.81−0.24 (-4.75%)
Close on Nov 12, 2026Market cap $482.75MP/E –Yield –
Shattuck Labs r&d expenses
Research and development expenses are spending on new products and technology.
Shattuck Labs's R&D Expenses for the twelve months ending Sep 30, 2026 was $53.27M, up 28.0% year over year. For fiscal 2025 it was $35.27M, down 47.5% from the year before. The highest annual figure on record is $82.90M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.27M | -47.5% |
| FY2024 | Dec 31, 2024 | $67.21M | -9.6% |
| FY2023 | Dec 31, 2023 | $74.31M | -10.4% |
| FY2022 | Dec 31, 2022 | $82.90M | +46.6% |
| FY2021 | Dec 31, 2021 | $56.56M | +50.9% |
| FY2020 | Dec 31, 2020 | $37.48M | +28.3% |
| FY2019 | Dec 31, 2019 | $29.22M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $21.57M | +183.1% |
| Q2 FY2026 | Jun 30, 2026 | $11.70M | +34.8% |
| Q1 FY2026 | Mar 31, 2026 | $10.95M | +10.4% |
| Q4 FY2025 | Dec 31, 2025 | $9.06M | -41.2% |
| Q3 FY2025 | Sep 30, 2025 | $7.62M | -53.3% |
| Q2 FY2025 | Jun 30, 2025 | $8.68M | -54.9% |
| Q1 FY2025 | Mar 31, 2025 | $9.92M | -39.0% |
| Q4 FY2024 | Dec 31, 2024 | $15.40M | +1.1% |
| Q3 FY2024 | Sep 30, 2024 | $16.31M | -32.6% |
| Q2 FY2024 | Jun 30, 2024 | $19.24M | +5.7% |
| Q1 FY2024 | Mar 31, 2024 | $16.26M | -2.4% |
| Q4 FY2023 | Dec 31, 2023 | $15.23M | -30.4% |
| Q3 FY2023 | Sep 30, 2023 | $24.21M | +28.4% |
| Q2 FY2023 | Jun 30, 2023 | $18.21M | -20.7% |
| Q1 FY2023 | Mar 31, 2023 | $16.67M | -13.1% |
| Q4 FY2022 | Dec 31, 2022 | $21.89M | +35.0% |
| Q3 FY2022 | Sep 30, 2022 | $18.86M | +24.6% |
| Q2 FY2022 | Jun 30, 2022 | $22.96M | +54.3% |
| Q1 FY2022 | Mar 31, 2022 | $19.19M | +85.6% |
| Q4 FY2021 | Dec 31, 2021 | $16.21M | +65.6% |
| Q3 FY2021 | Sep 30, 2021 | $15.14M | +28.2% |
| Q2 FY2021 | Jun 30, 2021 | $14.88M | +91.9% |
| Q1 FY2021 | Mar 31, 2021 | $10.34M | +27.0% |
| Q4 FY2020 | Dec 31, 2020 | $9.79M | +11.6% |
| Q3 FY2020 | Sep 30, 2020 | $11.80M | +48.6% |
| Q2 FY2020 | Jun 30, 2020 | $7.76M | – |
| Q1 FY2020 | Mar 31, 2020 | $8.14M | – |
| Q4 FY2019 | Dec 31, 2019 | $8.77M | – |
| Q3 FY2019 | Sep 30, 2019 | $7.95M | – |
See a number that looks wrong?